Sulforaphane induces apoptosis in adipocytes via Akt/p70s6k1/Bad inhibition and ERK activation

被引:36
|
作者
Yao, Anjun [1 ]
Shen, Yingzhuo [1 ,2 ]
Wang, Anshi [1 ]
Chen, Shiyong [1 ]
Zhang, Huiqin [1 ]
Chen, Fen [3 ]
Chen, Zhongming [4 ]
Wei, Hua [1 ]
Zou, Zuquan [1 ]
Shan, Yujuan [5 ]
Zhang, Xiaohong [1 ]
机构
[1] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China
[2] YinZhou Dist Ctr Dis Control, Ningbo, Zhejiang, Peoples R China
[3] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China
[4] Ningbo Kangning Hosp, Ningbo, Zhejiang, Peoples R China
[5] Harbin Inst Technol, Sch Food Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China
基金
美国国家科学基金会;
关键词
Sulforaphane; Adipocyte; Apoptosis; Akt; ERK; MAPK SIGNALING PATHWAYS; CELL-DEATH; MITOCHONDRIA; AMPK; PROTEINS; SURVIVAL; TRANSCRIPTION; ADIPOGENESIS; PI3K/AKT; OBESITY;
D O I
10.1016/j.bbrc.2015.08.049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sulforaphane (SFN), an isothiocyanate isolated from cruciferous vegetables, possesses anti-oxidant and anti-cancer bioactivities. Moreover, SFN exerts its pro-apoptotic effects in some cancer lines. However, the effects and mechanisms of SFN on the regulation of apoptosis of adipocytes are still unknown. In this study, we found that SFN induced significant apoptosis in 3T3-L1 adipocytes and markedly decreased the cellular lipid content. Western blot demonstrated that SFN-induced apoptosis was mediated via the mitochondrial apoptosis pathway based on increased cleavage of poly-ADP-ribose-polymerase (PARP), release of cytochrome c into the cytoplasm, and activation of caspase-3, as well as decreased Bcl-2/Bax ratio. In addition, SFN markedly decreased phosphorylation of Akt and downstream proteins, p70s6k1 and Bad, and increased phosphorylation of ERK. Therefore, our findings clarified that SFN could induce 3T3-L1 adipocyte apoptosis via down-regulation of the Akt/p70s6k1/Bad pathway and up-regulation of the ERK pathway, suggesting SFN may be a promising agent for the treatment or prevention of obesity. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:696 / 701
页数:6
相关论文
共 50 条
  • [11] PF-4708671 Activates AMPK Independently of p70S6K1 Inhibition
    Vainer, Gilad W.
    Saada, Ann
    Kania-Almog, Juliane
    Amartely, Adir
    Bar-Tana, Jacob
    Hertz, Rachel
    [J]. PLOS ONE, 2014, 9 (09):
  • [12] Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1
    Chen, Gui-hao
    Xu, Chuan-sheng
    Zhang, Jie
    Li, Qing
    Cu, He-he
    Li, Xiang-dong
    Chang, Li-ping
    Tang, Rui-jie
    Xu, Jun-yan
    Tian, Xia-qiu
    Huang, Pei-sen
    Xu, Jun
    Jin, Chen
    Yang, Yue-jin
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [13] The correlation of the AKT/mTOR/p70S6K1 pathway and VEGF in human epithelial ovarian cancer
    Trinh, X.
    Tjalma, W. A.
    Dirix, L. Y.
    Vermeulen, P. B.
    Van den Eynden, G. G.
    Van Laere, S. J.
    Van der Auwera, I.
    van Dam, P. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [14] INHIBITION OF MIR-128-3P BY TONGXINLUO PROTECTS HUMAN CARDIOMYOCYTES FROM ISCHEMIA/REPERFUSION INJURY VIA UPREGULATION OF P70S6K1/P-P70S6K1
    Chen, Guihao
    Xu, Chuansheng
    Yang, Yuejin
    Zhang, Jie
    Li, Qing
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 174 - 174
  • [15] SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis
    Li, Heng
    Tian, Zhufang
    Qu, Yiping
    Yang, Qi
    Guan, Haixia
    Shi, Bingyin
    Ji, Meiju
    Hou, Peng
    [J]. ONCOGENE, 2019, 38 (03) : 345 - 359
  • [16] SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis
    Heng Li
    Zhufang Tian
    Yiping Qu
    Qi Yang
    Haixia Guan
    Bingyin Shi
    Meiju Ji
    Peng Hou
    [J]. Oncogene, 2019, 38 : 345 - 359
  • [17] IGF-1R inhibition activates p70S6K1 to promote survival via MEK1/2 activation in colon cancer cells
    Wang, Qing
    Yang, Hsin-Sheng
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [18] The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
    X B Trinh
    W A A Tjalma
    P B Vermeulen
    G Van den Eynden
    I Van der Auwera
    S J Van Laere
    J Helleman
    E M J J Berns
    L Y Dirix
    P A van Dam
    [J]. British Journal of Cancer, 2009, 100 : 971 - 978
  • [19] The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
    Trinh, X. B.
    Tjalma, W. A. A.
    Vermeulen, P. B.
    Van den Eynden, G.
    Van der Auwera, I.
    Van Laere, S. J.
    Helleman, J.
    Berns, Emjj
    Dirix, L. Y.
    van Dam, P. A.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (06) : 971 - 978
  • [20] Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma
    Spaan, Ingrid
    Timmerman, Laura M.
    Kimman, Thomas
    Slomp, Anne
    Cuenca, Marta
    van Nieuwenhuijzen, Niels
    Moesbergen, Laura M.
    Minnema, Monique C.
    Raymakers, Reinier A.
    Peperzak, Victor
    [J]. BLOOD ADVANCES, 2021, 5 (12) : 2593 - 2607